Michael Kalberer is only the second person in the world to receive a groundbreaking CRISPR gene therapy aimed at correcting a genetic mutation responsible for causing a form of inherited retinal disorder. Michael and his doctors at Mass Eye and Ear, a member of Mass General Brigham, explain their experiences in the trial, which is the first use of CRISPR inside the body. Read more about Michael: [ Ссылка ]
